Abstract:55 Pancreatic transplantation is an important therapeutic alternative for type I diabetic patients with renal failure. Since systemic immunosuppression is required to prevent acute rejection and maintain long-term graft function, the enthusiasm for pancreas transplantation to restore normoglycemia and prevent the complications in non-uremic diabetic patients is muted. Inhibition of the CD28/B7 pathway during T cell activation by CTLA4Ig produces a state of T cell anergy, resulting in prolonged graft survival and donor-specific tolerance. We hypothesized that local production of CTLA4Ig from the pancreas graft, achieved by adenoviral-mediated transfer of the CTLA4Ig gene to the graft ex vivo, may inhibit the immune responses against the pancreas and promote long-term graft survival. Methods: Pancreaticoduodenal grafts from Lewis donors were infected by AdlacZ or AdCTLA4Ig via arterial perfusion of 2.5×1010 virus, followed by 1.5-hour ex vivo incubation at 4°C. Grafts were washed with saline and transplanted into STZ-diabetic recipients (Lewis or W/F). Syngeneic AdlacZ-infected grafts were harvested at various time points after transplantation and LacZ expression was examined by X-gal staining. All animals with graft rejection were sacrificed at the time of rejection, and graft morphology examined histologically. To determine the local vs. the systemic effect of the locally delivered CTLA4Ig, co-transplantation of the transfected pancreas with non-transfected heart allografts were performed in two allogeneic strain combinations. Results: X-gal staining of pancreas isografts demonstrated lacZ gene expression in the endocrine and exocrine cells of the donor grafts beginning 1 day post-transplantation, reaching peak levels by day 3. LacZ expression was also observed in the recipient liver, however, by day 7 lacZ expression diminished in the liver, and virtually disappeared by day 14, though high levels of LacZ in the pancreas grafts were detected. AdCTLA4Ig toxicity was evaluated by syngeneic transplantation of virus-infected pancreases (n=4) and a survival time of greater than 100 days was achieved. Transplantation of control (non-treated, n=6) or AdlacZ-infected Lewis rat pancreases (n=4) into W/F recipients gave a mean survival time of 17 and 17.5 days, respectively. However, transplantation of AdCTLA4Ig-infected pancreas grafts (n=6) resulted in permanent survival of the graft (> 100 days). Subsequent transplantation of donor strain hearts (n=3) did not induce rejection, and long-term heart allograft survival was observed. Transplantation of third party (ACI) heart allografts (n=3) were rejected, though the survival time of the grafts was prolonged to a small degree vs. control (MST 22d vs. 7d, p<0.01). In the co-transplantation model, the non-transfected hearts (H) were rejected while the transfected pancreases (Pd) were accepted, confirming the effect of locally delivered CTLA4Ig. TableTableConclusion: This study demonstrates that arterial perfusion of the pancreas with adenovirus can lead to successful viral infection and gene transfer. Local expression of the CTLA4Ig gene can produce long-term graft survival and donor-specific tolerance in the rat pancreas transplant model. The immunosuppressive effect of CTLA4Ig protein appears limited to the transfected tissue rather than a systemic phenomenon.

Porcine CTLA4-Ig prolong islet xenografts in rats by downregulating the direct pathway of T-cell activation.

Effect of Porcine Islet Loading Adv-porcine CTLA4-Ig Blocking the Direct Recognition Pathway in Xenotransplantation

Effect of AVV-hCTLA4-1g Transfection of Porcine Islets on Survival of Grafts in Mice

Effect of CTLA4-Ig gene transfer on rejection of rat islet xenografts]

[Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].

Blockade of Both Cd28/B7 and Ox40/Ox40l Co-Stimulatory Signal Pathways Prolongs the Survival of Islet Xenografts

Effects of CTLA4Ig modified bone marrow mesenchymal stem cells on the rejection of rat islet xenografts

LOCAL EXPRESSION OF RECOMBINANT CTLA4IG GENE IN THE PANCREAS INDUCES PERMANENT PANCREAS GRAFT SURVIVAL AND DONOR-SPECIFIC TOLERANCE:

Alternative Immunomodulatory Strategies for Xenotransplantation: CD80/CD86-CTLA4 Pathway-Modified Immature Dendritic Cells Promote Xenograft Survival.

Effects of CTLA4Ig and CD40LIg modified bone marrow mesenchymal stem cells on rejection of rat islet xenografts

Effects of Anti-CD40L Monoclonal Antibody on Rejection of Rat Pancreatic Islet Xenografts

IMPROVED SURVIVAL OF BIOLISTICALLY TRANSFECTED MOUSE ISLET ALLOGRAFTS EXPRESSING CTLA4-Ig OR SOLUBLE FAS LIGAND1

The Introduction of Human Heme Oxygenase-1 and Soluble Tumor Necrosis Factor-α Receptor Type I With Human IgG1 Fc in Porcine Islets Prolongs Islet Xenograft Survival in Humanized Mice

Experimental Study on Immune Tolerance Induced by Human Ad-CTLA-4Ig in Rats with Pancreaticoduodenal Transplantation

Blockade of the OX40/OX40L Pathway and Induction of PD-L1 Synergistically Protects Mouse Islet Allografts from Rejection.

Adoptive Transfer of Xenoantigen‑stimulated T Cell Receptor Vβ‑restricted Human Regulatory T Cells Prevents Porcine Islet Xenograft Rejection in Humanized Mice.

Rejection of xenogeneic porcine islets in humanized mice is characterized by graft‐infiltrating Th17 cells and activated B cells

Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway

Simultaneous blockade of the CD40/CD40L and NF-κB pathways prolonged islet allograft survival.

Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation model.

Induction of Islet Transplantation Tolerance with Anti-Cd4, Anti-Cd8 Immunotoxins and Donor Soluble Antigen.